invenicapital.com Report : Visit Site

Technical data of the invenicapital.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host invenicapital.com. Currently, hosted in Finland and its service provider is Javerdel Oy .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.2.16 (Debian) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to main content toggle navigation home team portfolio news contact inveni capital inveni capital offers entrepreneurial venture capital to life science companies in northern and central europe. inveni capital, established in 2007, is a life science focused venture capital firm. inveni capital invests in early to growth stage pharmaceutical development and medical technology companies in northern and central europe. inveni capital has office in helsinki, finland. inveni secondaries inveni secondaries manages the former bio fund ventures funds. the management of these life science dedicated funds was transferred to inveni secondaries in summer 2010. inveni secondaries has office in helsinki, finland. search for: news herantis pharma initiates patient recruitment for clinical study with lymfactin® in breast cancer associated lymphedema 18.5.2016 herantis pharma receives orphan designation of cdnf for treatment of als 29.3.2016 woodcast products are now fsc certified 12.1.2016 finnish medicines agency authorization of first-in-man clinical study with lymfactin 13.11.2015 air padding for woodcast® – offer unbeatable comfort for your patients! 30.10.2015 woodcast brings some colour to casting! 8.10.2015 herantis pharma granted almost 3 million euro government loan for parkinson study 30.6.2015 herantis pharma announces results from phase 2 cis-uca dry eye study 3.6.2015 onbone ltd raises €10m from international investor syndicate for the global launch of its novel casting/splinting products 14.4.2015 herantis pharma’s phase 2 dry eye study recruitment completed ahead of schedule 11.3.2015 woodcast was awarded in the new tree 2014 competition 2.2.2015 herantis pharma has initiated phase 2 study with cis-uca eye drops in patients with dry eye syndrome, results expected in q3/2015 7.1.2015 herantis pharma announces fda clearance of ind for phase 2 study of cis-uca eye drops 8.9.2014 biosilta completes eur 2.5 million ($3.4 million) funding round 11.6.2014 herantis pharma successfully completes its initial public offering 2.6.2014 medeia therapeutics ltd to participate in a new eu project 30.9.2013 onbone receives the mediaward 2013 3.9.2013 medtentia helix ring for mitral valve repair continues to achieve all objectives in approval study 31.7.2013 biosilta introduces enpresso b growth systems for bacterial cultures 24.6.2013 lead discovery collaboration on protein protein interaction targets with proteros 9.4.2013

URL analysis for invenicapital.com

http://www.invenicapital.com/2015/11/13/finnish-medicines-agency-authorization-of-first-in-man-clinical-study-with-lymfactin/
http://www.invenicapital.com/2013/06/24/biosilta-introduces-enpresso-b-growth-systems-for-bacterial-cultures/
http://www.invenicapital.com/2015/06/03/herantis-pharma-announces-results-from-phase-2-cis-uca-dry-eye-study/
http://www.invenicapital.com/2015/10/30/air-padding-for-woodcast-offer-unbeatable-comfort-for-your-patients/
http://www.invenicapital.com/2015/06/30/herantis-pharma-granted-almost-3-million-euro-government-loan-for-parkinson-study/
http://www.invenicapital.com/2015/03/11/herantis-pharmas-phase-2-dry-eye-study-recruitment-completed-ahead-of-schedule/
http://www.invenicapital.com/2015/02/02/woodcast-was-awarded-in-the-new-tree-2014-competition/
http://www.invenicapital.com/2016/01/12/woodcast-products-are-now-fsc-certified/
http://www.invenicapital.com/#content
http://www.invenicapital.com/2013/09/30/medeia-therapeutics-ltd-to-participate-in-a-new-eu-project/
http://www.invenicapital.com/contact/
http://www.invenicapital.com/2013/09/03/onbone-receives-the-mediaward-2013/
http://www.invenicapital.com/2015/10/08/woodcast-brings-some-colour-to-casting/
http://www.invenicapital.com/team/
http://www.invenicapital.com/2013/07/31/medtentia-helix-ring-for-mitral-valve-repair-continues-to-achieve-all-objectives-in-approval-study/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: INVENICAPITAL.COM
Registry Domain ID: 494307077_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2018-06-23T07:17:48Z
Creation Date: 2006-06-22T06:46:07Z
Registry Expiry Date: 2019-06-22T06:46:07Z
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +442070159370
Domain Status: ok https://icann.org/epp#ok
Name Server: NS1.JAVERDEL.COM
Name Server: NS2.JAVERDEL.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-09-05T04:25:57Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =invenicapital.com

  PORT 43

  TYPE domain

DOMAIN

  NAME invenicapital.com

  CHANGED 2018-06-23

  CREATED 2006-06-22

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS1.JAVERDEL.COM 195.60.252.17

  NS2.JAVERDEL.COM 94.199.112.12

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .